NR 293 Edapt

Student Name

Chamberlain University

NR-293: Pharmacology for Nursing Practice

Prof. Name

Date

Week 3: Gas Exchange and Bronchodilators

Introduction to Bronchodilators

Gas exchange is an essential physiological process that ensures oxygen delivery and carbon dioxide removal from the body. Nurses play a critical role in assessing respiratory function and implementing timely interventions. Pharmacological management, particularly the use of bronchodilators, is central to promoting airway patency and improving ventilation. Bronchodilators enhance airflow by dilating the bronchial smooth muscles, reducing airway inflammation, and facilitating secretion clearance. While some medications act independently, others combine different pharmacological mechanisms to optimize therapeutic effects. Understanding their classifications and uses is vital for safe and effective clinical practice.

Conditions Treated by Respiratory Medications

Respiratory medications address a wide range of chronic and acute conditions, such as:

• Allergies and seasonal hay fever

• Asthma

• Chronic obstructive pulmonary disease (COPD)

• Chronic bronchitis

• Emphysema

These medications improve quality of life by relieving symptoms, preventing exacerbations, and enhancing long-term respiratory function.

Rescue Inhalers and Drug Classifications

Short-acting inhaled beta2-agonists (SABAs) are primarily recommended as “rescue” medications during acute episodes of breathlessness. They are not intended for daily long-term maintenance therapy. Aside from SABAs, other classifications of respiratory drugs include bronchodilators, antihistamines, decongestants, expectorants, and antitussives.

Table 1

Classification of Respiratory Medications

Use of Respiratory Medications

Respiratory drugs are essential in treating both chronic and emergency respiratory conditions. For instance, adrenergic agents can enhance cardiac output and stimulate bronchodilation during acute respiratory distress. Nurses must tailor interventions based on patient-specific symptoms and responses to therapy.

Types of Bronchodilators

Antihistamines

Antihistamines block histamine receptors, which decreases smooth muscle constriction, reduces secretions, and lowers capillary permeability. They are particularly useful in conditions such as allergic rhinitis and anaphylaxis.

Decongestants

Decongestants fall into adrenergic, anticholinergic, and corticosteroid categories. Their primary role is reducing nasal mucosal swelling, which improves airflow and relieves congestion.

Antitussives

These agents suppress the cough reflex by acting on the brain’s cough center. They are beneficial for patients experiencing persistent or nonproductive coughing.

Expectorants

Expectorants thin respiratory secretions, making it easier for patients to expel mucus from the respiratory tract.

Short-Acting Beta-Adrenergic Agonists (SABA)

SABAs, such as albuterol, act quickly to relax bronchial smooth muscle during acute bronchospasms. They are considered life-saving during asthma exacerbations by improving airflow and oxygenation.

Patient Example: Valine, a 24-year-old nursing student diagnosed with asthma, experiences shortness of breath after physical activity. For immediate symptom relief, her provider prescribes a SABA inhaler such as albuterol.

Long-Acting Beta2 Agonists (LABA)

In contrast to SABAs, LABAs (e.g., salmeterol, formoterol) are used for long-term maintenance of asthma and COPD. They are administered twice daily and often combined with inhaled corticosteroids for optimal control. These agents should never be used alone for acute bronchospasm.

Anticholinergics

Ipratropium is one of the most common anticholinergic bronchodilators, particularly for COPD, bronchitis, and emphysema. It blocks acetylcholine-mediated bronchoconstriction, leading to airway dilation.

Mechanism of Action

Acetylcholine is a neurotransmitter that contributes to bronchial smooth muscle contraction. By blocking acetylcholine receptors, anticholinergics reduce bronchospasms and promote airflow.

Table 2

Contraindications of Ipratropium

Adverse Effects of Anticholinergics

Common side effects include dry mouth, cough, nausea, nervousness, and headache. Serious but rare reactions involve paradoxical bronchospasm and anaphylaxis.

Drug Interactions with Ipratropium

Ipratropium is contraindicated with revefenacin, another COPD inhaler, due to overlapping mechanisms. Additionally, caution is advised when used with:

Table 3

Ipratropium Interactions

Dosage Information

Ipratropium is usually administered as a 0.02% nebulized solution, providing 0.25–0.5 mg per 2.5 mL dose.

Table 4

Dosage Guidelines for Ipratropium

Patient Education

Patient education ensures proper inhaler or nebulizer use and reduces risks of misuse.

Table 5

Patient Teaching for Ipratropium

Critical advice includes avoiding eye exposure (especially in glaucoma patients) and seeking urgent care if breathing worsens suddenly.

Albuterol: A Beta Agonist

Introduction to Albuterol

Albuterol is classified as a short-acting beta-2 adrenergic agonist (SABA) and functions primarily as a bronchodilator. It is commonly prescribed for respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD) where patients experience bronchospasm. The drug can be taken orally or via inhalation, although the inhaled route is preferred because it provides a quicker onset of action and greater therapeutic effectiveness compared to oral administration.

Indications for Use

The primary indication for albuterol is the management of reversible obstructive airway conditions, including asthma and COPD. It is also effective in preventing exercise-induced bronchospasm when taken prior to physical activity. Beyond respiratory applications, albuterol has additional therapeutic roles in other systems due to its adrenergic properties—for instance, it can be used in the management of hypotension and certain cases of shock.

Mechanism of Action

Albuterol selectively stimulates beta-2 adrenergic receptors in bronchial smooth muscles, resulting in relaxation and subsequent bronchodilation. This process increases airflow to the lungs, improving oxygenation. However, stimulation of beta-2 receptors in other systems, such as the cardiovascular and nervous systems, may also occur, potentially leading to systemic side effects such as palpitations or nervousness.

Table 1. Medication Effects and Affected Systems

Contraindications and Adverse Effects

Albuterol should not be used in patients with hypersensitivity to the drug. It is also contraindicated in individuals with cardiovascular conditions such as uncontrolled hypertension, arrhythmias, or ischemic heart disease due to the risk of exacerbating these conditions.

Common side effects include:

• Chest pain

• Tachycardia (rapid heartbeat)

• Dizziness

• Nervousness or restlessness

• Headaches

Dosing Guidelines for Albuterol

Albuterol is available in both inhaled and oral forms. Inhaled formulations are favored due to their rapid absorption and quicker onset of action. Appropriate dosing is critical to avoid toxicity.

Table 2. Albuterol Dosage Recommendations

Important Considerations:

• Patients must be instructed on proper inhaler technique to ensure drug delivery to the lungs.

• Rinsing the mouth after inhalation is recommended to prevent oral irritation and dental issues.

Patient Education for Albuterol

Educating patients about safe albuterol use is crucial for effective treatment and prevention of complications.

Table 3. Key Educational Points for Patients

Effective patient education ensures better adherence, safe drug use, and improved treatment outcomes.

Theophylline: An Overview

Mechanism of Action and Drug Effects

Theophylline is primarily prescribed for the prevention of acute asthma attacks but is not suitable as a rescue medication. Its exact mechanism is not completely understood; however, it is known to increase intracellular cyclic adenosine monophosphate (cAMP) by inhibiting phosphodiesterase and antagonizing adenosine receptors. These actions lead to bronchodilation and respiratory stimulation.

Theophylline is metabolized into caffeine in the body, which explains its central nervous system (CNS) stimulant effects. Similar to caffeine, it can increase respiratory rate by acting on the medulla, enhance cardiac output at higher doses, and exert diuretic effects by improving renal filtration.

Contraindications

Theophylline is contraindicated in patients with hypersensitivity to the drug. Caution should be exercised in populations such as neonates, infants, and the elderly, as well as in patients with cardiovascular disease, seizure disorders, peptic ulcer disease, liver impairment, or sepsis.

Table 4. Populations Requiring Caution with Theophylline

Tobacco and Theophylline

Does smoking affect theophylline levels? Yes. Tobacco significantly alters theophylline metabolism. Smoking induces the CYP1A2 enzyme, which accelerates the drug’s metabolism and lowers its therapeutic effect. Consequently, smokers often require higher doses to achieve desired outcomes. If a patient begins or quits smoking during therapy, dosage adjustments are necessary to maintain effective serum concentrations.

Adverse Effects

What side effects may patients experience when taking theophylline?
Since theophylline is metabolized into caffeine, its adverse effects resemble those of caffeine, such as:

• Nervousness

• Insomnia

• Gastrointestinal upset

• Palpitations

• Seizures at toxic levels

Drug Interactions

Theophylline is metabolized via the cytochrome P450 (CYP450) system, making it prone to drug-drug interactions.

Table 5. Theophylline Drug Interactions

Dosages and Therapeutic Range

Theophylline is available in extended-release oral tablets (100–600 mg) and injectable solutions. It has a narrow therapeutic index, requiring close monitoring to prevent toxicity.

Table 6. Therapeutic Serum Levels of Theophylline

Patient Education for Theophylline

Key educational points include:

• Do not use theophylline as a rescue drug during asthma attacks.

• Report smoking history, alcohol use, or any changes in smoking habits to your provider.

• Avoid crushing or chewing extended-release capsules.

• Never double doses if a dose is missed.

• Pregnant or breastfeeding women should consult their healthcare provider before use.

• Report persistent fever, nausea, or neurological changes.

References

American Lung Association. (2023). Understanding asthma medications. https://www.lung.org

Global Initiative for Asthma (GINA). (2023). Global strategy for asthma management and prevention. https://ginasthma.org

NR 293 Edapt

National Heart, Lung, and Blood Institute. (2022). COPD management guidelines. https://www.nhlbi.nih.gov

U.S. Food & Drug Administration (FDA). (2022). Medication guide: Ipratropium bromide inhalation solution. https://www.fda.gov